Biomarkers news from FierceHealthcare
NewsNew Alzheimer guidelines focus on diagnosis
Memory impairment will no longer be the main criteria related to the diagnosis of Alzheimer's disease under new guidelines released Tuesday by the National Institute on Aging and the Alzheimer's Read more...
Drugmakers agree to six-month DTC delay
Under fire over direct-to-consumer ads, which some Congressional legislators contend are misleading to consumers, pharmaceutical companies have agreed to voluntarily wait six months after drugs are Read more...
| Press ReleasesMayo Clinic Study Identifies Earliest Stages of Alzheimer’s DiseaseROCHESTER, Minn.--(BUSINESS WIRE)-- Addressing the earliest stages of Alzheimer’s disease, before a patient shows outward signs of cognitive problems, has sometimes been a challenge for physicians Read more >> Definiens to Introduce New Generation of Products for Tissue-based Biomarker Research at the International Definiens SymposiumMUNICH, Sept. 20, 2011 /PRNewswire/ -- Definiens, the leading Health Image Intelligence™ company, announces that it will release a new generation of products at the International Definiens Symposium Read more >> Cleveland HeartLab Completes $18.4-Million Financing RoundProceeds will support company’s growth through accelerated adoption, commercialization of cardiovascular disease biomarkers CLEVELAND--(BUSINESS WIRE)-- Cleveland HeartLab Inc. (CHL), a leading Read more >> Council on Competitiveness Showcases Power of High Performance Computing in Case Study with GNS HealthcareCutting the Cost of Health Care Through Advanced Modeling and Simulation Technology WASHINGTON, June 30, 2011 /PRNewswire-USNewswire/ -- The Council on Competitiveness, in partnership with the Read more >> 100th Customer Commissioned on Alere's Apollo Health Management System26.5 million participants now eligible for next-generation systemATLANTA, June 16, 2011 /PRNewswire/ -- Alere Health, LLC, one of the nation's leading providers of integrated health and wellness Read more >> |
